Belgium
As of 11 December 2024, the platform FarmaStatus (application that collects information about the availability of medicines in Belgium) will undergo multiple changes:
- Change in lay-out FarmaStatus: The application will get a similar lay-out as other applications, f.e. FarmaInfo
- Deletion of the status ‘interruption commercialization’: This status will no longer exist. All unavailabilities, whether shorter or longer than one year, will have to be reported as ‘temporary unavailability’.
- Unavailabilities established by the FAMHP: The FAMHP itself will be able to create or modify notifications of temporary unavailabilities in well-defined circumstances
More information can be found in the manual in the FarmaStatus FAQ and attached.
Source:
Communication AFMPS – FAGG